Results 211 to 220 of about 79,715 (267)
Some of the next articles are maybe not open access.

Labetalol Hepatotoxicity

Annals of Internal Medicine, 1990
The Food and Drug Administration has received 11 reports of cases (three fatal) in the United States in which hepatocellular damage was associated with labetalol. The temporal circumstances strongly implicate labetalol; the conditions of nine patients improved after cessation of labetalol therapy, and one patient had a recurrence after therapy was ...
J A, Clark, H J, Zimmerman, L A, Tanner
openaire   +2 more sources

Acetaminophen hepatotoxicity

Gastroenterology, 1980
This review of acetaminophen hepatotoxicity begins with a history of the drug and consideration of the scope of its current use. The molecular basis for hepatotoxicity is discussed and this serves as a background for delineation of its clinical manifestations and treatment.
openaire   +3 more sources

Acetaminophen Hepatotoxicity

Clinics in Liver Disease, 2007
Acetaminophen is a commonly used antipyretic and analgesic agent. It is safe when taken at therapeutic doses; however, overdose can lead to serious and even fatal hepatotoxicity. The initial metabolic and biochemical events leading to toxicity have been well described, but the precise mechanism of cell injury and death is unknown. Prompt recognition of
openaire   +2 more sources

Oxacillin and Hepatotoxicity

Annals of Internal Medicine, 1979
Excerpt To the editor: The report of Onorata and Axelrod in the October issue (1) emphasizes the otherwise poorly recognized risk of hepatotoxicity from high-dose intravenous oxacillin.
openaire   +2 more sources

Hepatotoxicity of thiazolidinediones

Expert Opinion on Drug Safety, 2003
Thiazolidinediones are insulin sensitisers now widely used for the treatment of Type 2 diabetes mellitus. The initial marketed drug in this class, troglitazone, was removed from the market worldwide after approximately 3 years of use due to rare but severe hepatotoxicity, which sometimes resulted in liver failure leading to the need for liver ...
openaire   +2 more sources

Molindone and Hepatotoxicity

Drug Intelligence & Clinical Pharmacy, 1985
An adolescent male with chronic schizophrenic disorder, paranoid type, was treated with molindone. He developed hepatotoxicity in the early treatment phase as evidenced by flu-like symptoms and laboratory abnormalities of liver functions. These symptoms and his hepatic functions improved on discontinuing molindone.
S C, Bhatia, L E, Banta, D W, Ehrlich
openaire   +2 more sources

Hepatotoxicity of Chemotherapy

Seminars in Oncology, 2006
The selection of an antineoplastic regimen for an oncology patient is based first on the availability of effective drugs and then on a balancing of potential treatment-related toxicities with the patient's clinical condition and associated comorbidities. Liver function abnormalities are commonly observed in this patient population and identifying their
Justin, Floyd   +3 more
openaire   +2 more sources

Hepatotoxicity of Antidepressants

International Clinical Psychopharmacology, 1991
Detection of abnormal liver function tests in a patient receiving an antidepressant or other psychopharmacological agent presents a major problem to the clinician, who must decide whether or not to withdraw a drug which may be of central importance in the patient's management.
openaire   +2 more sources

Hepatotoxicity of Mercaptopurine

JAMA, 1964
In a study of 49 leukemic patients, jaundice occurred in 16 of 38 who were treated with mercaptopurine (6-mercaptopurine), but only in one of 11 not receiving the drug. In eight patients jaundice cleared up rapidly on cessation of mercaptopurine therapy, and there was a recurrence of jaundice in two who were rechallenged with the drug.
M, EINHORN, I, DAVIDSOHN
openaire   +2 more sources

Aspirin Hepatotoxicity

American Journal of Health-System Pharmacy, 1978
A case of aspirin hepatotoxicity in a 46-year-old male with rheumatoid arthritis is discussed, and this adverse reaction is reviewed. The patient was started on 900 mg aspirin four times daily; five days later the dose was increased to 1200 mg four times daily. After six days' therapy of 4.8 g aspirin daily, the serum salicylate level rose to 25 mg/100
S A, Kanada, W M, Kolling, B I, Hindin
openaire   +2 more sources

Home - About - Disclaimer - Privacy